Empyema Caused by Peptoniphilus asaccharolyticus and Complicated by Secondary Pulmonary Infection from Acinetobacter baumannii: A Case Report.

IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES
Infection and Drug Resistance Pub Date : 2024-10-21 eCollection Date: 2024-01-01 DOI:10.2147/IDR.S485235
Min Chai, Patajiang Yusufu, Yixin Chen, Jiannan Chai, Xinran Yang, Yuqi Xiao, Hongwei Long, Dilimulat Maimaiti, Dahai Xu
{"title":"Empyema Caused by <i>Peptoniphilus asaccharolyticus</i> and Complicated by Secondary Pulmonary Infection from <i>Acinetobacter baumannii</i>: A Case Report.","authors":"Min Chai, Patajiang Yusufu, Yixin Chen, Jiannan Chai, Xinran Yang, Yuqi Xiao, Hongwei Long, Dilimulat Maimaiti, Dahai Xu","doi":"10.2147/IDR.S485235","DOIUrl":null,"url":null,"abstract":"<p><p><i>Peptoniphilus asaccharolyticus</i> is a gram-positive anaerobic coccus that can cause infections in immunocompromised individuals. <i>P. asaccharolyticus</i> causing empyema has not been reported earlier. Here, we present a novel case of empyema caused by <i>P. asaccharolyticus</i>. A 72-year-old male had a constant fever with difficulty breathing. A chest computed tomography scan revealed infiltration in the right lower lobe and pleural effusion. Following hospital admission, pleural fluid drainage was conducted, and the culture isolated <i>P. asaccharolyticus</i>. Initially treated with piperacillin/tazobactam, the patient experienced excessive thick sputum production, prompting a tracheostomy. Subsequent sputum cultures identified <i>Acinetobacter baumannii</i>. After transitioning to cefoperazone/sulbactam for antibiotic treatment and continued pleural effusion drainage, recovery was achieved. Empyema can be caused by <i>P. asaccharolyticus</i> and further complicated by a secondary infection with <i>A. baumannii</i>. Management should include appropriate antibiotic therapy, pleural drainage, vigilant monitoring, and supportive care. We aim to raise clinicians' awareness of the potential for <i>P. asaccharolyticus</i> to cause empyema in immunocompromised patients and to provide early treatments, thereby improving morbidity and mortality.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"17 ","pages":"4531-4537"},"PeriodicalIF":2.9000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11505558/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection and Drug Resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IDR.S485235","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Peptoniphilus asaccharolyticus is a gram-positive anaerobic coccus that can cause infections in immunocompromised individuals. P. asaccharolyticus causing empyema has not been reported earlier. Here, we present a novel case of empyema caused by P. asaccharolyticus. A 72-year-old male had a constant fever with difficulty breathing. A chest computed tomography scan revealed infiltration in the right lower lobe and pleural effusion. Following hospital admission, pleural fluid drainage was conducted, and the culture isolated P. asaccharolyticus. Initially treated with piperacillin/tazobactam, the patient experienced excessive thick sputum production, prompting a tracheostomy. Subsequent sputum cultures identified Acinetobacter baumannii. After transitioning to cefoperazone/sulbactam for antibiotic treatment and continued pleural effusion drainage, recovery was achieved. Empyema can be caused by P. asaccharolyticus and further complicated by a secondary infection with A. baumannii. Management should include appropriate antibiotic therapy, pleural drainage, vigilant monitoring, and supportive care. We aim to raise clinicians' awareness of the potential for P. asaccharolyticus to cause empyema in immunocompromised patients and to provide early treatments, thereby improving morbidity and mortality.

由胰溶解酵母菌引起的肺水肿并发鲍曼不动杆菌继发肺部感染:病例报告。
溶糖梭状芽孢杆菌(Peptoniphilus asaccharolyticus)是一种革兰氏阳性厌氧球菌,可导致免疫力低下者感染。阿苏卡氏菌引起肺水肿的病例尚未见报道。在此,我们介绍一例由阿苏卡雷氏菌引起的新发肺水肿病例。一名 72 岁的男性持续发烧,呼吸困难。胸部计算机断层扫描显示其右下叶有浸润和胸腔积液。入院后,进行了胸腔积液引流,培养分离出了阿苏糖杆菌。最初使用哌拉西林/他唑巴坦治疗,但患者痰液过多,导致气管切开。随后的痰培养发现了鲍曼不动杆菌。在改用头孢哌酮/舒巴坦进行抗生素治疗并继续进行胸腔积液引流后,患者痊愈。溶血性脓胸可由阿苏卡氏菌引起,继发鲍曼不动杆菌感染会使病情进一步复杂化。处理方法应包括适当的抗生素治疗、胸腔引流、警惕性监测和支持性护理。我们的目标是提高临床医生对溶葡萄球菌可能导致免疫力低下患者出现肺水肿的认识,并提供早期治疗,从而改善发病率和死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Infection and Drug Resistance
Infection and Drug Resistance Medicine-Pharmacology (medical)
CiteScore
5.60
自引率
7.70%
发文量
826
审稿时长
16 weeks
期刊介绍: About Journal Editors Peer Reviewers Articles Article Publishing Charges Aims and Scope Call For Papers ISSN: 1178-6973 Editor-in-Chief: Professor Suresh Antony An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信